World's Best Scientists 2026 revealed!
Award Badge
Medicine
Portugal
2025

D-Index & Metrics

Medicine

D-Index
107
Citations
72305
World Ranking
6099
National Ranking
4

Research.com Recognitions

  • 2025 - Research.com Medicine in Portugal Leader Award

Overview

Fatima Cardoso is affiliated with the Champalimaud Foundation in Portugal and has contributed extensively to research in the fields of medicine, with a strong focus on oncology. Their work encompasses subfields including oncology, cancer research, pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and genetics.

Their research covers a range of topics related to cancer treatment and epidemiology. Key areas of study include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • BRCA Gene Mutations in Cancer
  • Cancer Treatment and Pharmacology
  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer

Cardoso's publication record includes notable articles such as:

  • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5), 2020, Annals of Oncology
  • Current and future burden of breast cancer: Global statistics for 2020 and 2040, 2022, The Breast
  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021, 2021, Annals of Oncology
  • Pembrolizumab for Early Triple-Negative Breast Cancer, 2020, New England Journal of Medicine
  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers, 2020, Cell

Frequent publication venues include:

  • The Breast
  • Cancer Research
  • Annals of Oncology
  • Journal of Clinical Oncology
  • European Journal of Cancer

Cardoso collaborates often with a group of researchers who appear frequently as co-authors. These include:

  • Martine Piccart
  • Nadia Harbeck
  • Giuseppe Curigliano
  • Javier Cortés
  • Coralie Poncet

The combination of research topics, frequent collaborations, and choice of publication venues characterizes a research trajectory centered on improving understanding and treatment of breast cancer and related oncological challenges.

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

    Christos Sotiriou;Pratyaksha Wirapati;Sherene Loi;Adrian Harris

  • Pembrolizumab for Early Triple-Negative Breast Cancer.

    Peter Schmid;Javier Cortes;Lajos Pusztai;Heather McArthur

  • Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    E. Senkus;S. Kyriakides;F. Penault-Llorca;P. Poortmans

  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    F. Cardoso;A. Costa;E. Senkus;M. Aapro

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets

  • Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer

    Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale

  • Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.

    E de Azambuja;F Cardoso;G de Castro;M Colozza

  • Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

    Javier Cortes;Joyce O'Shaughnessy;David Loesch;Joanne J.L. Blum

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series,

    Christine Desmedt;Fanny Piette;Sherene Loi;Yixin Wang

  • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

    F. Cardoso;A. Costa;L. Norton;E. Senkus

  • Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. Cardoso;L. Fallowfield;A. Costa;M. Castiglione

  • Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

    Stephen Chan;Max E. Scheulen;Stephen Johnston;Klaus Mross

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

    H J Burstein;G Curigliano;B Thürlimann;W P Weber

  • Clinical application of the 70-gene profile: the MINDACT trial.

    Fatima Cardoso;Laura Van't Veer;Emiel Rutgers;Sherene Loi

  • Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations

    Larissa A. Korde;Jo Anne Zujewski;Leah Kamin;Sharon Hermes Giordano

  • High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

    Ana Maria Gonzalez-Angulo;Jennifer K Litton;Kristine R Broglio;Funda Meric-Bernstam

  • HER2-Low Breast Cancer: Pathological and Clinical Landscape.

    Paolo Tarantino;Paolo Tarantino;Erika Hamilton;Sara M Tolaney;Javier Cortes

Frequent Co-Authors

Martine Piccart
Martine Piccart Université Libre de Bruxelles
Christos Sotiriou
Christos Sotiriou Université Libre de Bruxelles
Denis Larsimont
Denis Larsimont Université Libre de Bruxelles
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Jonas Bergh
Jonas Bergh Karolinska Institute
Giuseppe Viale
Giuseppe Viale University of Milan
Marianne Paesmans
Marianne Paesmans Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to medicine can open up flexible and affordable pathways into healthcare careers. For registered nurses looking to advance, understanding the average cost of rn to bsn programs is crucial when planning your education budget. Many online RN to BSN programs offer affordability and flexibility for working professionals.

If you hold a non-nursing bachelor’s degree, pursuing an online direct entry msn could be the fastest way to enter advanced nursing roles. These programs are tailored for career changers eager to join the healthcare sector quickly.

Admission requirements can differ greatly. Prospective nursing students often search for what is the easiest nursing school to get into to find programs that best match their qualifications and chances of acceptance.

For those interested in healthcare administration, exploring medical billing and coding online schools that accept financial aid can lead to lucrative, in-demand jobs with high job security—all from the convenience of online learning.

Best Scientists Citing Fatima Cardoso

Trending Scientists